Literature DB >> 6181563

Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer.

H M Jensen, I Chen, M R DeVault, A E Lewis.   

Abstract

Normal human breast lobules, freshly isolated by precision microdissection of tissue stained with methylene blue chloride, were assayed for their ability to induce neovascularization (angiogenesis) in rabbit irises. Histologically, normal lobules from cancerous breast induced angiogenesis twice as often as lobules from noncancerous breasts, suggesting that preneoplastic transformation is diffuse.

Entities:  

Mesh：

Year:  1982        PMID： 6181563     DOI： 10.1126/science.6181563

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  20 in total

Review 1.  Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour.

Authors:  N Garcia de la Torre; H E Turner; J A H Wass
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

Review 2.  Angiogenesis: possibilities for therapeutic interventions.

Authors:  W Wynendaele; A T van Oosterom; A Pawinski; E A de Bruijn; R A Maes
Journal:  Pharm World Sci       Date:  1998-12

Review 3.  Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

Authors:  Nishant S Gandhi; Rakesh K Tekade; Mahavir B Chougule
Journal:  J Control Release       Date:  2014-09-07       Impact factor: 9.776

Review 4.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

Review 5.  Molecular magnetic resonance contrast agents for the detection of cancer: past and present.

Authors:  Alexei Bogdanov; Mary L Mazzanti
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

6.  Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.

Authors:  Jehana James; Daryl J Murry; Anthony M Treston; Anna Maria Storniolo; George W Sledge; Carolyn Sidor; Kathy D Miller
Journal:  Invest New Drugs       Date:  2006-09-13       Impact factor: 3.850

Review 7.  Toward checkmate: biology and breast cancer therapy for the new millennium.

Authors:  K D Miller; G W Sledge
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

8.  Bevacizumab in the treatment of patients with advanced breast cancer: where have we landed?

Authors:  L Y Dirix; P A Van Dam; A M Prove; P B Vermeulen
Journal:  Ther Adv Med Oncol       Date:  2010-09       Impact factor: 8.168

Review 9.  Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland.

Authors:  Carmen Clapp; Stéphanie Thebault; Gonzalo Martínez de la Escalera
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

10.  Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma--results of a multiparametric study.

Authors:  P Bevilacqua; M Barbareschi; P Verderio; P Boracchi; O Caffo; P Dalla Palma; S Meli; N Weidner; G Gasparini
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.